Oxford scientists have developed a novel new malaria vaccine which can protect against the deadly mosquito-borne disease. The vaccine has shown promising results in the first clinical trial to test whether it can protect people against the disease. The trial was carried out by researchers led by Professor Adrian Hill of the Jenner Institute at Oxford University, along with colleagues from the biotechnology company Okairos. Some of the adult volunteers were completely protected against malaria in this initial study of the vaccine’s efficacy, researchers said. It’s the first time that a vaccine has been shown to have a protective effect through a sufficiently high immune response involving cells called CD8 T cells. It is CD8 immune cells that are seen to mount a protective response against malaria in similar studies in mice. Every existing vaccine in use – bar one – generates antibodies. But there are two arms to the body’s immune system for...
🔒 Premium Content - For Free
Unlock this content by becoming a Global Health Press subscriber. Join for exclusive articles, expert research, and valuable insights!




